Navigation

Roche and Ciba Specialty Chemicals enjoy turnover success

The Basel-based pharmaceuticals giant, Roche, has reported a 17 per cent increase in turnover in the first quarter of this year, compared to the same period in 1999.

This content was published on April 13, 2000 - 09:59

The Basel-based pharmaceuticals giant, Roche, has reported a 17 per cent increase in turnover in the first quarter of this year, compared to the same period in 1999.

The biggest growth areas were the concern's pharmaceuticals division, with a turnover of more than SFr4.5 billion, and diagnostics with a turnover of Sfr1.4 billion.

Roche also said its vitamins and pure chemicals divisions managed to hold their market position while the aroma and flavour division showed a positive performance in the last quarter. The company says it is optimistic for the rest of the year.

Ciba's Specialty Chemicals division enjoyed an incease in turnover of 16 per cent, to Sfr2.44 billion, compared to the same period last year. Sales in the first quarter also rose by 4 per cent, compared to the last quarter of 1999.

swissinfo and agencies

Articles in this story

This article was automatically imported from our old content management system. If you see any display errors, please let us know: community-feedback@swissinfo.ch

In compliance with the JTI standards

In compliance with the JTI standards

More: SWI swissinfo.ch certified by the Journalism Trust Initiative

Contributions under this article have been turned off. You can find an overview of ongoing debates with our journalists here. Please join us!

If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.

Share this story

Change your password

Do you really want to delete your profile?